867P The association between polygenic risk of autoimmune disease, progression-free survival (PFS), and pathway-level transcriptomic signatures predictive of anti-PD1 response in melanoma
Owen, C.N., Richenberg, G., Gray, V., Nounu, A., Robinson, T., Kar, S.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma
Owen, C.N., Bai, X., Quah, T., Lo, S.N., Allayous, C., Callaghan, S., Martínez-Vila, C., Wallace, R., Bhave, P., Reijers, I.L.M., Thompson, N., Vanella, V., Gerard, C.L., Aspeslagh, S., Labianca, A., Khattak, A., Mandala, M., Xu, W., Neyns, B., Michielin, O., Blank, C.U., Welsh, S.J., Haydon, A., Sandhu, S., Mangana, J., McQuade, J.L., Ascierto, P.A., Zimmer, L., Johnson, D.B., Arance, A., Lorigan, P., Lebbé, C., Carlino, M.S., Sullivan, R.J., Long, G.V., Menzies, A.M.
Published in Annals of oncology (01.07.2021)
Published in Annals of oncology (01.07.2021)
Get full text
Journal Article
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy
Owen, C.N., Shoushtari, A.N., Chauhan, D., Palmieri, D.J., Lee, B., Rohaan, M.W., Mangana, J., Atkinson, V., Zaman, F., Young, A., Hoeller, C., Hersey, P., Dummer, R., Khattak, M.A., Millward, M., Patel, S.P., Haydon, A., Johnson, D.B., Lo, S., Blank, C.U., Sandhu, S., Carlino, M.S., Larkin, J.M.G., Menzies, A.M., Long, G.V.
Published in Annals of oncology (01.08.2020)
Published in Annals of oncology (01.08.2020)
Get full text
Journal Article
1138P Delayed immune-related adverse events (irAEs) on anti-PD1-based therapy
Owen, C.N., Bai, X., Quah, T., Lo, S., Callaghan, S., Martínez-Vila, C., Bhave, P., Reijers, I., Gerard, C.L., Aspelagh, S., Xu, W., Welsh, S.J., Sandhu, S., Mangana, J., McQuade, J.L., Ascierto, P.A., Zimmer, L., Johnson, D.B., Lebbé, C., Menzies, A.M.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
UK multicentre real-world data of the use of cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer
Gullick, G., Owen, C.N., Watkins, W.J., Cook, S., Helbrow, J., Reed, H., Squires, R., Park, S., Weir, E., Aquilina, F., Webber, N., Nye, E., Atkinson, C., Blair, C., Halstead, A., Daniels, E., Alves, A., Chew, S., Thomas, W., Spensley, S., Beresford, M., Bowen, R., Robinson, T.
Published in ESMO Real World Data and Digital Oncology (01.09.2024)
Published in ESMO Real World Data and Digital Oncology (01.09.2024)
Get full text
Journal Article
Wood, fuelwood, and non-wood forest products
Sizer, N, Bass, S, Mayers, J, Arnold, J.E.M, Auckland, L, Belcher, B, Bird, N, Campbell, B.M, Carle, J, Cleary, D, Counsell, S, Enters, T, Fernando, K, Gullison, T, Hudson, J, Kellison, B, Klingberg, T, Owen, C.N, Sampson, N, Vermeulen, S, Wollenberg, E, Shackleton, S, Edmunds, D
Year of Publication 2005
Get more information
Year of Publication 2005
Publication